Search

Your search keyword '"Cellerino, Maria"' showing total 223 results

Search Constraints

Start Over You searched for: Author "Cellerino, Maria" Remove constraint Author: "Cellerino, Maria"
223 results on '"Cellerino, Maria"'

Search Results

2. On the Assessment of Gray Code Kernels for Motion Characterization in People with Multiple Sclerosis: A Preliminary Study

3. Predicting disease severity in multiple sclerosis using multimodal data and machine learning

4. Signs and symptoms of COVID‐19 in patients with multiple sclerosis

5. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

6. Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study

7. Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study

8. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

9. Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS

10. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic

11. Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study

13. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

16. Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy.

18. Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients

21. Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab

22. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

23. Multiscale networks in multiple sclerosis

24. Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis.

26. Predicting disease severity in multiple sclerosis using multimodal data and machine learning

27. Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial

29. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.

30. Impact of treatment on cellular immunophenotype in MS: A cross-sectional study

32. Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis

33. Clinical and radiological correlates of apathy in multiple sclerosis.

34. In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis

35. Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities

36. Multiscale networks in multiple sclerosis

37. CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis

39. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

41. Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review

42. Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

44. Central Vein Sign and advanced diffusion MRI to differentiate demyelinating from comorbidities-related white matter lesions in patients with multiple sclerosis (P1-1.Virtual)

46. Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study.

47. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial

48. Predictors of ocrelizumab effectiveness in patients with multiple sclerosis

50. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

Catalog

Books, media, physical & digital resources